
Patients with autoimmune bullous diseases (AIBDs) have faced considerable challenges during the COVID‐19 outbreak.SARS‐CoV‐2 vaccines became an important public health solution, but the pandemic raised awareness of vaccine hesitancy.We aimed to investigate the currently unknown general vaccination status among AIBD patients to better inform vaccine practices in this cohort of potentially life‐threatening inflammatory disorders...
Like
Save
Share